Insider · CIK 0001203841

TESTMAN THOMAS R

Reports to the SEC for 3 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001203841

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2009-07-27	ENDOCARE INCM Exercise/Conversion	Former Director	MExercise/Conversion	+9,202 sh	—	—	9,202
2009-07-27	ENDOCARE INCM Exercise/Conversion	Former Director	MExercise/Conversion	+53.2K sh	—	—	62,360
2009-07-27	ENDOCARE INCU Disposition from Tender	Former Director	UDisposition from Tender	−62.4K sh	—	—	0
2009-07-27	ENDOCARE INCU Disposition from Tender	Former Director	UDisposition from Tender	−5,000 sh	—	—	0
2009-07-27	ENDOCARE INCRestricted stock unitsM Exercise/Conversion	Former Director	MExercise/Conversion	−9,202 sh	—	—	0
2009-07-27	ENDOCARE INCDeferred stock unitsM Exercise/Conversion	Former Director	MExercise/Conversion	−53.2K sh	—	—	0
2009-05-15	ENDOCARE INCM Exercise/Conversion	Former Director	MExercise/Conversion	+7,142 sh	—	—	9,202
2009-05-15	ENDOCARE INCRestricted stock unitsD Disposition to Issuer	Former Director	DDisposition to Issuer	−7,142 sh	—	—	0
2009-01-10	ENDOCARE INCM Exercise/Conversion	Former Director	MExercise/Conversion	+2,060 sh	—	—	2,060
2009-01-08	ENDOCARE INCDeferred stock unitsA Award	Former Director	AAward	+21.3K sh	—	—	21,333
2008-04-07	ENDOCARE INCDeferred Stock UnitsA Award	Former Director	AAward	+2,373.42 sh	—	—	2,373.42
2007-08-16	ENDOCARE INCP Purchase	Former Director	PPurchase	+4,500 sh	$2.10	+$9,450	13,000
2007-08-16	ENDOCARE INCP Purchase	Former Director	PPurchase	+500 sh	$2.05	+$1,025	13,500
2007-08-16	ENDOCARE INCP Purchase	Former Director	PPurchase	+500 sh	$2.03	+$1,015	14,000
2007-08-16	ENDOCARE INCP Purchase	Former Director	PPurchase	+1,000 sh	$2.00	+$2,000	15,000
2007-06-01	AMYLIN PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$16.23	+$195K	14,000
2007-06-01	AMYLIN PHARMACEUTICALS INCS Sale	Director	SSale	−12K sh	$46.62	−$559K	2,000
2007-06-01	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2007-05-25	AMYLIN PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$16.99	+$340K	22,000
2007-05-25	AMYLIN PHARMACEUTICALS INCS Sale	Director	SSale	−20K sh	$44.88	−$898K	2,000
2007-05-25	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2006-08-28	ENDOCARE INCP Purchase	Former Director	PPurchase	+1,500 sh	$2.05	+$3,075	3,500
2006-08-28	ENDOCARE INCP Purchase	Former Director	PPurchase	+3,500 sh	$2.10	+$7,350	7,000
2006-08-25	ENDOCARE INCP Purchase	Former Director	PPurchase	+1,000 sh	$2.00	+$2,000	1,000
2006-08-25	ENDOCARE INCP Purchase	Former Director	PPurchase	+1,000 sh	$1.98	+$1,980	2,000
2006-01-10	ENDOCARE INCStock Option (Right to Buy)A Award	Former Director	AAward	+20K sh	—	—	20,000
2005-07-01	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+580 sh	$21.14	+$12.3K	4,439
2005-05-25	AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)J Other	Director	JOther	+12K sh	—	—	12,000
2005-01-10	ENDOCARE INCStock Option (Right to buy)A Award	Former Director	AAward	+12.5K sh	—	—	12,500
2004-12-30	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+425 sh	$23.58	+$10K	3,059
2004-12-30	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+100 sh	$23.56	+$2,356	3,159
2004-10-01	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+490 sh	$21.04	+$10.3K	2,534
2004-10-01	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+100 sh	$21.05	+$2,105	2,634
2004-08-11	AMYLIN PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,000 sh	$18.29	+$36.6K	2,000
2004-01-12	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+350 sh	$22.02	+$7,707	979
2004-01-02	ENDOCARE INCStock Option (Right to Buy)A Award	Former Director	AAward	+5,000 sh	—	—	5,000
2003-10-16	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+275 sh	$28.51	+$7,840.25	629
2003-07-08	AMYLIN PHARMACEUTICALS INCPhantom Stock-Deferred CompensationA Award	Director	AAward	+354 sh	$22.52	+$7,972.08	354
2003-04-01	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+505 sh	$15.85	+$8,004.25	980
2003-01-01	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+240 sh	$16.65	+$3,996	475
2002-12-02	AMYLIN PHARMACEUTICALS INCPhantom Stock UnitsA Award	Director	AAward	+235 sh	$16.99	+$3,992.65	235

Recent filings

Accepted (ET)
Jul 294
TESTMAN THOMAS R0001209191-09-038079
SEC(opens sec.gov)
May 194
TESTMAN THOMAS R0001209191-09-027599
SEC(opens sec.gov)
Jan 124
TESTMAN THOMAS R0001209191-09-002739
SEC(opens sec.gov)
Apr 94
ENDOCARE INC0001209191-08-023543
SEC(opens sec.gov)
Aug 164
ENDOCARE INC0001209191-07-048872
SEC(opens sec.gov)
Jun 44
AMYLIN PHARMACEUTICALS INC0001367982-07-000278
SEC(opens sec.gov)
May 294
AMYLIN PHARMACEUTICALS INC0001367982-07-000257
SEC(opens sec.gov)

Companies

Address

C/O ENDOCARE, INC. 201 TECHNOLOGY DRIVE

IRVINE, CA, 92618